Chemical Compound

Dhk-pgf2alpha

CAS Registry Number 27376-76-7
Dhk-pgf2alpha chemical structure
Primary Record

Dhk-pgf2alpha

In stock
7,272 g
Purity
98.9 %
CAS
27376-76-7

Compound Identifiers & Properties

CAS
27376-76-7
PubChem CID
5283039
SMILES
CCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O
Canonical SMILES
CCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O

Names & Synonyms

  • Dhk-pgf2alpha
  • PGFM
  • 13,14-Dihydro-15-keto-pgf2alpha
  • Prostaglandin FM
  • DKF2alpha
  • 15-keto-dihydro-PGF2alpha
  • Pulmonary metabolite-pgf2alpha
  • 15-K-DHPGF2alpha
  • 27376-76-7
  • RefChem:78369
  • 15-Keto-13,14-dihydro-pgf2alpha
  • AC1NR1DY
  • 15-KetodihydroPGF2alpha
  • 15-K-DH-PGF(2alpha)
  • 13,14-Dihydro-15-oxoprostaglandin F
  • D0X4NG
  • MLS000028871
  • 15-Keto-13,14-dihydroprostaglandin F2alpha
  • CHEBI:63976
  • 13,14-Dihydro-15-ketoprostaglandin F
  • 13,14-Dihydro-15-ketoprostaglandin F2alpha
  • VKTIONYPMSCHQI-XAGFEHLVSA-N
  • BML1-G01
  • DTXSID701019118
  • GTPL1901
  • C20H34O5
  • SCHEMBL23406932
  • 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA
  • 13,14-Dihydro-15-keto-PGF2|A
  • 13,14-Dihydro-15-ketodinoprost
  • HMS3648D18
  • 13,14-Dihydro-15-ketoPGF2?
  • 13,14-Dihydro-15-keto PGF2a
  • 15-Ketodihydroprostaglandin F2alpha
  • 9S,11S-dihydroxy-15-oxo-5Z-prostenoic acid
  • 13,14-Dihydro-15-ketoPGF2alpha
  • 15-Keto-13,14-dihydro-prostaglandin F2alpha
  • 15-Keto-13,14-dihydroprostaglandin F2-alpha
  • 1193AH
  • 13,14-dihydro-15-oxo-PGF2alpha
  • LMFA03010027
  • MFCD00135243
  • ZINC12496397
  • 13,14-dihydro-15-keto PGF2alpha
  • 13,14-dihydro-15-keto-PGF2 alpha
  • CID5283039
  • CID:5283039
  • 13,14-DIHYDRO-15-KETO-PGF2a
  • NCGC00161288-01
  • J39.477G
  • PD021301
  • SMR000058898
  • 13,14-dihydro-15-keto-Prostaglandin F2alpha
  • SID:251964002
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
  • 13,14-dihydro-15-keto-Prostaglandin F2a
  • 13,14-Dihydro-15-ketoprostaglandin F2|A
  • 15-keto-13,14-dihydroprostaglandinf2alpha
  • HY-113208
  • 13,14-Dihydro-15-oxoprostaglandin F2alpha
  • CS-0059317
  • 13,14,Dihydro-15-keto prostaglandin F2alpha
  • 13,14-Dihydro-15-keto-prostaglandin F2 alpha
  • 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2
  • C008228
  • SR-01000946490
  • SR-01000946490-1
  • (5Z)-9alpha,11alpha-Dihydroxy-15-oxoprost-5-en-1-oic acid
  • Q27070766
  • (5Z,9 alpha, 11 alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid
  • (5Z)-9alpha,11alpha-Dihydroxy-15-oxoprosta-5-ene-1-oic acid
  • (5Z,9S,11R)-9,11-Dihydroxy-15-oxoprosta-5-ene-1-oic acid
  • (5Z,9alpha,11 alpha)-9,11-Dihydroxy-15-oxoprost-5-en-1-oic acid
  • (5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid
  • (5Z,9alpha,11alpha)-9,11-Dihydroxy-15-oxoprosta-5-ene-1-oic acid
  • 13,14-dihydro-15-keto Prostaglandin F2alpha Lipid Maps(R) MS Standard
  • Prost-5-en-1-oic acid, 9,11-dihydroxy-15-oxo-, (5Z,9alpha,11alpha)-
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
  • (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl)hept-5-enoic acid